Denosumab Prescribing at CASTLEGATE AND DERWENT SURGERY
Drugs affecting bone metabolism | Endocrine System
Items (12m)
69
Total Quantity
74
NHS Cost
£13.3K
vs National Avg
+153.6%
CASTLEGATE AND DERWENT SURGERY prescribed 69 items of Denosumab over the last 12 months at a cost of £13,339 to the NHS. This is 153.6% above the national average prescribing rate. Denosumab is classified under Drugs affecting bone metabolism in the BNF.
Monthly Prescribing Trend
Jun 2026
2
Jun 2026
12
Jun 2026
5
Jun 2026
3
Jun 2026
5
Jun 2026
9
Jun 2026
1
Jun 2026
8
Jun 2026
4
Jun 2026
5
Jun 2026
4
Jun 2026
11
Prescribing Details
| Total Items | 69 |
|---|---|
| Total Quantity | 74 |
| Total NHS Cost | £13,339 |
| Presentations | 1 different forms |
| vs National Average | +153.6% |
Denosumab Prescribing Comparison
| This practice | 69 items |
|---|---|
| National average per practice | 27 items |
| Difference | +153.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.